
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Lymphocytic Esophagitis (LyE): Treatment Strategies & Comparison with Eosinophilic Esophagitis (EoE)</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Lymphocytic Esophagitis (LyE): Treatment Strategies &amp; Comparison with Eosinophilic Esophagitis (EoE)</strong></summary>
            <div>
                <ul><li>Information extracted from a medical text.</li><li>Authors: Not specified in provided text.</li><li>Journal: Not specified in provided text.</li><li>Publication Date: Not specified in provided text.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What percentage of LyE patients in Cochen et al.&#x27;s study showed improvement with PPIs?</li><li>2. What is the primary histopathological difference between LyE and EoE?</li><li>3. Which demographic group is typically more affected by LyE compared to EoE?</li><li>4. What is the diagnostic threshold for eosinophils per HPF in EoE?</li><li>5. What percentage of LyE patients in Habbal et al.&#x27;s study developed esophageal strictures?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Treatment of Lymphocytic Esophagitis (LyE)</strong></summary>
            <div>
                <ul><li>No consistent consensus for LyE treatment.</li><li>Regimens mainly based on EoE experience → clinical similarities.</li><li>Large studies proving efficacy of each treatment are lacking.</li></ul>
                
        <details>
            <summary><strong>Proton Pump Inhibitors (PPIs)</strong></summary>
            <div>
                <ul><li>Efficacy debated; some studies show improvement.</li><li>Cochen et al. [18]: 60% LyE patients improved w/ PPIs.</li><li>Nguen et al. [29] &amp; Sloan et al. [30]: confirmed PPI efficacy.</li></ul>
                
        <details>
            <summary><strong>Variable Efficacy &amp; Concerns</strong></summary>
            <div>
                <ul><li>Lee et al. [31]: 24% clinical improvement, 17% endoscopic improvement w/ PPIs.</li><li>Lee et al. [31]: PPIs not best option → may delay more effective treatments.</li><li>Genta [32]: PPIs ineffective in some; question if improvement is PPI-dependent.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Positive Outcomes</strong></summary>
            <div>
                <ul><li>Zaver et al. [13]: 86% clinical improvement in LyE patients following PPI treatment.</li><li>Improvement achieved w/ lower drug doses vs. EoE patient population.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Topical Corticosteroids</strong></summary>
            <div>
                <ul><li>Fairly effective treatment option.</li><li>Pasricha et al. [17]: observed improvement in patient treated w/ swallowed fluticasone.</li><li>Kasirye et al. [33]: resolution of dysphagia in LyE patient after swallowed fluticasone (220 micrograms, 3x daily regimen).</li></ul>
                
        <details>
            <summary><strong>Other Treatments in Pasricha Study</strong></summary>
            <div>
                <ul><li>Improvement also achieved in patients after administration of PPIs, systemic prednisone, and a &#x27;GI cocktail&#x27; (maalox, donnatal, lidocaine).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Endoscopic Esophageal Dilatation</strong></summary>
            <div>
                <ul><li>Necessary intervention for esophageal strictures.</li><li>Habbal et al. [14]: 12.9% of LyE patients develop esophageal strictures.</li></ul>
                
        <details>
            <summary><strong>Case Series by Jideh et al. [19]</strong></summary>
            <div>
                <ul><li>One patient required endoscopic esophageal dilatation @ 12-month intervals + concurrent PPI therapy.</li><li>Another patient experienced spontaneous resolution of symptoms.</li><li>Third patient achieved minimum symptom relief after PPI + topical corticosteroid therapy.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Disease Course &amp; Prognosis</strong></summary>
            <div>
                <ul><li>LyE is a benign chronic disease.</li><li>No malignant transformations observed to date [9].</li><li>Cochen et al. [9]: some patients&#x27; symptoms resolved both w/ and w/o treatment (mainly PPIs).</li></ul>
                
        <details>
            <summary><strong>Research Gap</strong></summary>
            <div>
                <ul><li>Large studies to assess natural course of disease + effectiveness of treatment are still lacking.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Comparison of Eosinophilic Esophagitis (EoE) and Lymphocytic Esophagitis (LyE)</strong></summary>
            <div>
                <ul><li>Clinical course of LyE very similar to EoE.</li><li>Dysphagia: leading pathological sign in both LyE + EoE patients.</li></ul>
                
        <details>
            <summary><strong>Similarities</strong></summary>
            <div>
                <ul><li>Endoscopic features remarkably similar.</li><li>Features range from unremarkable esophagus to fissures, white exudates, trachealization, and strictures.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Key Differences</strong></summary>
            <div>
                <ul><li>Demographics: EoE mainly affects younger male patients.</li><li>Demographics: LyE more common in older females.</li><li>Histopathological presentation: Main difference.</li></ul>
                
        <details>
            <summary><strong>Histopathological Distinctions</strong></summary>
            <div>
                <ul><li>EoE: eosinophilic infiltrate (&gt;15 eosinophils/HPF) in esophageal mucosa.</li><li>LyE: lymphocytic infiltrate.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Etiological Factors</strong></summary>
            <div>
                <ul><li>EoE: Atopy is an important etiological factor; disease is multifactorial.</li><li>LyE: Etiological factors largely unclear; role of atopy debated but not proven [8,34].</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Phenotypes of Esophagitis (Rubio et al. [35] Study)</strong></summary>
            <div>
                <ul><li>Identified four phenotypes of esophagitis based on histopathological + immunohistochemical findings.</li><li>Evaluated biopsies from 311 patients using dual staining procedure (H&amp;E-CD3).</li></ul>
                
        <details>
            <summary><strong>Diagnostic Criteria in Study</strong></summary>
            <div>
                <ul><li>LyE: &gt;40 lymphocytes/HPF.</li><li>Lymphocytic infiltration: &lt;39 lymphocytes/HPF.</li><li>EoE: &gt;15 eosinophils/HPF.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Findings</strong></summary>
            <div>
                <ul><li>28.3% (n=88) of patients diagnosed w/ LyE.</li><li>21.2% (n=66) of patients diagnosed w/ EoE.</li><li>10.6% (n=33) of patients diagnosed w/ concomitant EoE + LyE.</li><li>39.9% (n=124) of patients diagnosed w/ lymphocytic infiltration.</li></ul>
                
        <details>
            <summary><strong>Immunohistochemical Observations</strong></summary>
            <div>
                <ul><li>No immunohistochemical differences found between lymphocytes present in EoE + LyE.</li><li>Possible that lymphocytic infiltrate initiates eosinophilic inflammation [35].</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Role of T Cells in EoE</strong></summary>
            <div>
                <ul><li>Pasha et al. [36]: T cells play an important role in development of EoE.</li><li>Particularly significant in the active form of the disease.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
